Multiple Assemblies exist for SMTL entry 1nd0
CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG; X-RAY DIFFRACTION 2.45 Å

	SMTL ID 1nd0.1 Ligands SULFATE ION; (1S,4S)-4-[DIMETHYL(PHENYL)SILYL]-1-METHYLPIPERIDINE 1-OXIDE Polypeptides IMMUNOGLOBULIN IGG2A; IMMUNOGLOBULIN IGG2A Oligo-state hetero-oligomer
	SMTL ID 1nd0.2 Ligands SULFATE ION; (1S,4S)-4-[DIMETHYL(PHENYL)SILYL]-1-METHYLPIPERIDINE 1-OXIDE Polypeptides IMMUNOGLOBULIN IGG2A; IMMUNOGLOBULIN IGG2A Oligo-state hetero-oligomer
	SMTL ID 1nd0.3 Ligands SULFATE ION; (1S,4S)-4-[DIMETHYL(PHENYL)SILYL]-1-METHYLPIPERIDINE 1-OXIDE Polypeptides IMMUNOGLOBULIN IGG2A; IMMUNOGLOBULIN IGG2A Oligo-state hetero-oligomer
	SMTL ID 1nd0.4 Ligands SULFATE ION; (1S,4S)-4-[DIMETHYL(PHENYL)SILYL]-1-METHYLPIPERIDINE 1-OXIDE Polypeptides IMMUNOGLOBULIN IGG2A; IMMUNOGLOBULIN IGG2A Oligo-state hetero-oligomer
	SMTL ID 1nd0.5 Ligands SULFATE ION; (1S,4S)-4-[DIMETHYL(PHENYL)SILYL]-1-METHYLPIPERIDINE 1-OXIDE Polypeptides IMMUNOGLOBULIN IGG2A; IMMUNOGLOBULIN IGG2A Oligo-state hetero-oligomer
	SMTL ID 1nd0.6 Ligands SULFATE ION; (1S,4S)-4-[DIMETHYL(PHENYL)SILYL]-1-METHYLPIPERIDINE 1-OXIDE Polypeptides IMMUNOGLOBULIN IGG2A; IMMUNOGLOBULIN IGG2A Oligo-state hetero-oligomer